Home Business Page 21

Business

Generics acquisition in the U.S.

Acquisition and collaboration for cholesterol and neuroscience

Raw materials for the pharmaceutical industry

Primary clinical endpoint reached

New brand identity

New therapies against TNF-α

Collaboration for pharma services

New approaches for cancer therapy

Agreement for hepatitis C

Exclusive rights in Life Science

1...202122...29Page 21 of 29
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151